A5327 SWIFT-C is a Phase I, open-label, two-cohort clinical trial, in which between 44 and 50 acutely HCV-infected HIV-1...
Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...
A major disadvantage of giving SD NVP is the potential for maternal development of NVP resistance and additional resistance to...
P1078 is a Phase IV, randomized, double-blind, placebo-controlled study of HIV-infected pregnant women and the infants born to...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
